US Stock MarketDetailed Quotes

DARE Dare Bioscience

Watchlist
  • 3.7900
  • -0.2432-6.03%
Close Jul 1 16:00 ET
  • 3.6000
  • -0.1900-5.01%
Post 19:58 ET
31.93MMarket Cap-957P/E (TTM)

Dare Bioscience Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
9.3K
-71.92%2.81M
1.81M
1M
0
0
10M
0
0
10M
Operating revenue
--9.3K
-71.92%2.81M
--1.81M
--1M
--0
--0
--10M
--0
--0
--10M
Cost of revenue
Gross profit
Operating expense
-28.04%6.03M
-18.46%33.75M
-57.00%6.98M
31.62%9.4M
-6.51%8.99M
-0.21%8.38M
5.93%41.39M
70.08%16.23M
-43.65%7.14M
4.94%9.62M
Selling and administrative expenses
-19.60%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
19.68%2.68M
54.61%2.82M
-General and administrative expense
-19.60%2.7M
7.71%12.11M
-2.35%3.08M
1.69%2.72M
4.53%2.95M
30.83%3.36M
33.04%11.24M
29.97%3.15M
19.68%2.68M
54.61%2.82M
Research and development costs
-33.70%3.33M
-28.31%21.54M
-70.72%3.8M
49.58%6.67M
-11.09%6.04M
-13.53%5.02M
-1.88%30.04M
82.35%12.98M
-57.23%4.46M
-7.39%6.8M
Other operating expenses
----
0.00%100K
----
----
----
----
--100K
----
----
----
Operating profit
28.16%-6.02M
1.42%-30.94M
68.14%-5.17M
-17.62%-8.4M
-2,439.02%-8.99M
0.21%-8.38M
19.67%-31.39M
-70.08%-16.23M
43.65%-7.14M
104.19%384.32K
Net non-operating interest income expense
Other net income (expense)
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17.55%437.75K
34,353.72%287.34K
7,787.93%118.95K
16,857.71%29.68K
Other non- operating income (expenses)
-315.46%-732.88K
77.84%778.49K
-60.36%113.9K
-18.18%97.32K
665.35%227.12K
19,020.18%340.15K
17,271.03%437.75K
34,353.72%287.34K
7,787.93%118.95K
16,857.71%29.68K
Income before tax
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
104.52%414K
Income tax
Net income
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
104.52%414K
Net income continuous Operations
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
104.52%414K
Minority interest income
Net income attributable to the parent company
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
104.52%414K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
16.00%-6.76M
2.54%-30.16M
68.28%-5.06M
-18.22%-8.3M
-2,216.49%-8.76M
4.24%-8.04M
20.02%-30.95M
-67.08%-15.94M
44.58%-7.02M
104.52%414K
Basic earnings per share
22.22%-0.84
5.41%-4.2
68.42%-0.72
-12.50%-1.08
-2,145.48%-1.2
10.00%-1.08
41.27%-4.44
-5.56%-2.28
55.56%-0.96
102.72%0.0587
Diluted earnings per share
22.22%-0.84
5.41%-4.2
68.42%-0.72
-12.50%-1.08
-2,162.07%-1.2
10.00%-1.08
41.27%-4.44
-5.56%-2.28
55.56%-0.96
102.69%0.0582
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 9.3K-71.92%2.81M1.81M1M0010M0010M
Operating revenue --9.3K-71.92%2.81M--1.81M--1M--0--0--10M--0--0--10M
Cost of revenue
Gross profit
Operating expense -28.04%6.03M-18.46%33.75M-57.00%6.98M31.62%9.4M-6.51%8.99M-0.21%8.38M5.93%41.39M70.08%16.23M-43.65%7.14M4.94%9.62M
Selling and administrative expenses -19.60%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M19.68%2.68M54.61%2.82M
-General and administrative expense -19.60%2.7M7.71%12.11M-2.35%3.08M1.69%2.72M4.53%2.95M30.83%3.36M33.04%11.24M29.97%3.15M19.68%2.68M54.61%2.82M
Research and development costs -33.70%3.33M-28.31%21.54M-70.72%3.8M49.58%6.67M-11.09%6.04M-13.53%5.02M-1.88%30.04M82.35%12.98M-57.23%4.46M-7.39%6.8M
Other operating expenses ----0.00%100K------------------100K------------
Operating profit 28.16%-6.02M1.42%-30.94M68.14%-5.17M-17.62%-8.4M-2,439.02%-8.99M0.21%-8.38M19.67%-31.39M-70.08%-16.23M43.65%-7.14M104.19%384.32K
Net non-operating interest income expense
Other net income (expense) -315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17.55%437.75K34,353.72%287.34K7,787.93%118.95K16,857.71%29.68K
Other non- operating income (expenses) -315.46%-732.88K77.84%778.49K-60.36%113.9K-18.18%97.32K665.35%227.12K19,020.18%340.15K17,271.03%437.75K34,353.72%287.34K7,787.93%118.95K16,857.71%29.68K
Income before tax 16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M104.52%414K
Income tax
Net income 16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M104.52%414K
Net income continuous Operations 16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M104.52%414K
Minority interest income
Net income attributable to the parent company 16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M104.52%414K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 16.00%-6.76M2.54%-30.16M68.28%-5.06M-18.22%-8.3M-2,216.49%-8.76M4.24%-8.04M20.02%-30.95M-67.08%-15.94M44.58%-7.02M104.52%414K
Basic earnings per share 22.22%-0.845.41%-4.268.42%-0.72-12.50%-1.08-2,145.48%-1.210.00%-1.0841.27%-4.44-5.56%-2.2855.56%-0.96102.72%0.0587
Diluted earnings per share 22.22%-0.845.41%-4.268.42%-0.72-12.50%-1.08-2,162.07%-1.210.00%-1.0841.27%-4.44-5.56%-2.2855.56%-0.96102.69%0.0582
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg